Clinical Trial

Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone

Study acronym: ICON
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Evaluation of the effect iberdomide combined with low-dose cyclophosphamide and dexamethasone in patients with relapsed/refractory multiple myeloma.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2020-05-13; most recent amendment 2025-03-27.
Status change: Recruiting → Active, Not Recruiting 2023-08-15
Status change: Not Yet Recruiting → Recruiting 2021-02-16
Trial Details
NCT Number NCT04392037
Lead Sponsor Amsterdam UMC, location VUmc
Collaborators: Celgene
Conditions Multiple Myeloma
Enrollment 60 participants
Start Date 2021-02-17
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-28